[Retracted] mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

Figure 1

A correlation between miR-126-5p expression and cisplatin sensitivity of NSCLC: (a) miR-126-5p levels in NSCLC tumor tissues () and the nontumor counterparts (); (b) miR-126-5p levels in NSCLC sensitive () and resistance groups (); (c) miR-126-5p levels in BESA-2B, A549, A549/DDP, H1650, and H1650/DDP groups; (d) MTT assay-based detection of IC50 values in A549 and A549/DDP groups; (e) MTT assay-based detection of IC50 values in H1650 and H1650/DDP groups; (f) quantitative and statistical analysis of IC50 for each group. , , and .

(a)

(b)

(c)

(d)

(e)

(f)